So if we’re right, each former human is now essentially a radio transmitter and receiver. One plurb sends out a signal that ...

Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of its latest peer-reviewed paper in Scientific Reports: "A brief visual ...

Amplitude Inc. (NASDAQ: AMPL) is a leading AI-powered product analytics platform enabling companies to better understand how customers engage with their digital products and services. It tracks ...

Abstract: Current terahertz direct modulators suffer from significant reflections during modulation. This paper proposes an absorptive terahertz amplitude modulator based on dual-path coherent ...

Amplitude is undervalued, trading at less than 4x forward revenue, despite a strong recurring revenue base and improving retention rates. Q2 results showed accelerating revenue growth, a ...

Abstract: The demand for ultra-low-power wireless connectivity motivates the study of backscatter communication technology. There are already some related products on the market based on excitation ...

Founded in 1997 in Valence, Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopedics. Amplitude Surgical develops and markets high-end ...

Discover the groundbreaking AMPLITUDE trial results, showcasing niraparib's effectiveness in treating metastatic prostate cancer with minimal safety concerns. Gerhardt Attard, MD, PhD, FRCP, a ...

Investors interested in Business Services stocks should always be looking to find the best-performing companies in the group. Amplitude, Inc. (AMPL) is a stock that can certainly grab the attention of ...